<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32653817</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43<sup>A315T</sup> mouse model: A PET-MR study.</ArticleTitle><Pagination><StartPage>102327</StartPage><MedlinePgn>102327</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102327</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2020.102327</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(20)30164-9</ELocationID><Abstract><AbstractText>Currently TAR DNA binding protein 43 (TDP-43) pathology, underlying Amyotrophic Lateral Sclerosis (ALS), remains poorly understood which hinders both clinical diagnosis and drug discovery efforts. To better comprehend the disease pathophysiology, positron emission tomography (PET) and multi-parametric magnetic resonance imaging (mp-MRI) provide a non-invasive mode to investigate molecular, structural, and neurochemical abnormalities in vivo. For the first time, we report the findings of a longitudinal PET-MR study in the TDP-43<sup>A315T</sup> ALS mouse model, investigating disease-related changes in the mouse brain. 2-deoxy-2-[<sup>18</sup>F]fluoro-D-glucose [<sup>18</sup>F]FDG PET showed significantly lowered glucose metabolism in the motor and somatosensory cortices of TDP-43<sup>A315T</sup> mice whereas metabolism was elevated in the region covering the bilateral substantia nigra, reticular and amygdaloid nucleus between 3 and 7&#xa0;months of age, as compared to non-transgenic controls. MR spectroscopy data showed significant changes in glutamate&#xa0;+&#xa0;glutamine (Glx) and choline levels in the motor cortex and hindbrain of TDP-43<sup>A315T</sup> mice compared to controls. Cerebral blood flow (CBF) measurements, using an arterial spin labelling approach, showed no significant age- or group-dependent changes in brain perfusion. Diffusion MRI indices demonstrated transient changes in different motor areas of the brain in TDP-43<sup>A315T</sup> mice around 14&#xa0;months of age. Cytoplasmic TDP-43 proteinaceous inclusions were observed in the brains of symptomatic, 18-month-old mice, but not in non-symptomatic transgenic or wild-type mice. Our results reveal that disease- and age-related functional and neurochemical alterations, together with limited structural changes, occur in specific brain regions of transgenic TDP-43<sup>A315T</sup> mice, as compared to their healthy counterparts. Altogether these findings shed new light on TDP-43<sup>A315T</sup> disease pathogenesis and may prove useful for clinical management of ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weerasekera</LastName><ForeName>Akila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biomedical MRI Unit/MoSAIC, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium; A.A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School (MGH/HMS), Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crabb&#xe9;</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Nuclear Medicine, Department of Imaging and Pathology, KU Leuven, Belgium; MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium. Electronic address: melissa.crabbe@sckcen.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tom&#xe9;</LastName><ForeName>Sandra O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Neurosciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gsell</LastName><ForeName>Willy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Biomedical MRI Unit/MoSAIC, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sima</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Icometrix, R&amp;D department, Leuven, Belgium; Department of Electrical Engineering (ESAT), STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casteels</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Nuclear Medicine, Department of Imaging and Pathology, KU Leuven, Belgium; MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dresselaers</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Radiology, Department of Imaging and Pathology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deroose</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Nuclear Medicine, Department of Imaging and Pathology, KU Leuven, Belgium; MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Huffel</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Electrical Engineering (ESAT), STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudolf Thal</LastName><ForeName>Dietmar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Neurosciences, KU Leuven, Leuven, Belgium; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Department of Neurosciences, KU Leuven, Leuven, Belgium; Center for Brain &amp; Disease Research, VIB, Leuven, Belgium; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Himmelreich</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Biomedical MRI Unit/MoSAIC, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C088568">aspartyl-arginyl-valyl-tyrosyl-isoleucyl-histidyl-prolyl-phenylalanyl-histidyl-leucyl-valyl-isoleucyl-histidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Magnetic Resonance Imaging</Keyword><Keyword MajorTopicYN="N">Magnetic Resonance Spectroscopy</Keyword><Keyword MajorTopicYN="N">Multimodal Imaging</Keyword><Keyword MajorTopicYN="N">Positron Emission Tomography</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. DRT received speaker honorary from Novartis Pharma AG (Switzerland) and Biogen (USA), travel reimbursement from GE-Healthcare (UK) and UCB (Belgium) and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32653817</ArticleId><ArticleId IdType="pmc">PMC7352080</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2020.102327</ArticleId><ArticleId IdType="pii">S2213-1582(20)30164-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agosta, F., Altomare, D., Festari, C., Orini, S., Gandolfo, F., Boccardi, M., Arbizu, J., Bouwman, F., Drzezga, A., Nestor, P., Nobili, F., Walker, Z., Pagani, M., 2018. Disorders E-ETFftPoF-PfDN Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease. Eur. J. Nucl. Med. Mol. Imaging 45, 1546&#x2013;1556. doi:10.1007/s00259-018-4033-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">29717332</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., van den Berg L.H., Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., Ling S.C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A., Da Cruz S., Clutario K.M., Swing D., Tessarollo L., Marsala M., Shaw C.E., Yeo G.W., Cleveland D.W. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. U S A. 2013;110:E736&#x2013;745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin J.A., Wright G.S., Watanabe S., Grossmann J.G., Antonyuk S.V., Yamanaka K., Hasnain S.S. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc. Natl. Acad. Sci. U S A. 2014;111:4309&#x2013;4314. doi: 10.1073/pnas.1317317111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1317317111</ArticleId><ArticleId IdType="pmc">PMC3964094</ArticleId><ArticleId IdType="pubmed">24591609</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 2010;30:639&#x2013;649. doi: 10.1523/JNEUROSCI.4988-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Beel S., Herdewyn S., Fazal R., De Decker M., Moisse M., Robberecht W., Van Den Bosch L., Van Damme P. Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice. Mol. Neurodegener. 2018;13:55. doi: 10.1186/s13024-018-0288-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0288-y</ArticleId><ArticleId IdType="pmc">PMC6192075</ArticleId><ArticleId IdType="pubmed">30326935</ArticleId></ArticleIdList></Reference><Reference><Citation>Belousov A.B., O'Hara B.F., Denisova J.V. Acetylcholine becomes the major excitatory neurotransmitter in the hypothalamus in vitro in the absence of glutamate excitation. J. Neurosci. 2001;21:2015&#x2013;2027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762624</ArticleId><ArticleId IdType="pubmed">11245685</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouter C., Henniges P., Franke T.N., Irwin C., Sahlmann C.O., Sichler M.E., Beindorff N., Bayer T.A., Bouter Y. (18)F-FDG-PET detects drastic changes in brain metabolism in the Tg4-42 model of Alzheimer's disease. Front. Aging Neurosci. 2018;10:425. doi: 10.3389/fnagi.2018.00425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00425</ArticleId><ArticleId IdType="pmc">PMC6333025</ArticleId><ArticleId IdType="pubmed">30670962</ArticleId></ArticleIdList></Reference><Reference><Citation>Casteels C., Vunckx K., Aelvoet S.A., Baekelandt V., Bormans G., Van Laere K., Koole M. Construction and evaluation of quantitative small-animal PET probabilistic atlases for [(1)(8)F]FDG and [(1)(8)F]FECT functional mapping of the mouse brain. PLoS ONE. 2013;8 doi: 10.1371/journal.pone.0065286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065286</ArticleId><ArticleId IdType="pmc">PMC3676471</ArticleId><ArticleId IdType="pubmed">23762335</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chio A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski M.D., Powell S.Z., Peterson L.E., Appel J.W., Rivera A.L., Takei H., Chang E., Appel S.H. Clinical significance of TDP-43 neuropathology in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2017;76:402&#x2013;413. doi: 10.1093/jnen/nlx025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx025</ArticleId><ArticleId IdType="pmc">PMC5901081</ArticleId><ArticleId IdType="pubmed">28521037</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Hulst L., Van Weehaeghe D., Chio A., Calvo A., Moglia C., Canosa A., Cistaro A., Willekens S.M., De Vocht J., Van Damme P., Pagani M., Van Laere K. Multicenter validation of [(18)F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 2018:1&#x2013;8. doi: 10.1080/21678421.2018.1476548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1476548</ArticleId><ArticleId IdType="pubmed">29862846</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte J.M., Lei H., Mlynarik V., Gruetter R. The neurochemical profile quantified by in vivo 1H NMR spectroscopy. Neuroimage. 2012;61:342&#x2013;362. doi: 10.1016/j.neuroimage.2011.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2011.12.038</ArticleId><ArticleId IdType="pubmed">22227137</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte J.M., Do K.Q., Gruetter R. Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by 1H magnetic resonance spectroscopy. Neurobiol. Aging. 2014;35:1660&#x2013;1668. doi: 10.1016/j.neurobiolaging.2014.01.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.135</ArticleId><ArticleId IdType="pubmed">24560998</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertay T., Sencan Eren M., Karaman M., Oktay G., Durak H. (18)F-FDG-PET/CT in initiation and progression of inflammation and infection. Mol. Imaging Radionucl. Ther. 2017;26:47&#x2013;52. doi: 10.4274/mirt.18291.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/mirt.18291</ArticleId><ArticleId IdType="pmc">PMC5472086</ArticleId><ArticleId IdType="pubmed">28613196</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili M.A., Panahi M., Yadav S., Hennings L., Kiaei M. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int. J. Exp. Pathol. 2013;94:56&#x2013;64. doi: 10.1111/iep.12006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iep.12006</ArticleId><ArticleId IdType="pmc">PMC3575874</ArticleId><ArticleId IdType="pubmed">23317354</ArticleId></ArticleIdList></Reference><Reference><Citation>Firbank M.J., Harrison R.M., O'Brien J.T. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dement Geriatr. Cogn. Disord. 2002;14:64&#x2013;76. doi: 10.1159/000064927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000064927</ArticleId><ArticleId IdType="pubmed">12145453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M.L., Perry G., Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. 2018 doi: 10.1111/jnc.14327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo S., Anzilotti S., Coda A.R., Gramanzini M., Greco A., Panico M., Vinciguerra A., Zannetti A., Vicidomini C., Dolle F., Pignataro G., Quarantelli M., Annunziato L., Brunetti A., Salvatore M., Pappata S. Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT. Eur. J. Nucl. Med. Mol. Imaging. 2016;43:1348&#x2013;1359. doi: 10.1007/s00259-016-3311-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-016-3311-y</ArticleId><ArticleId IdType="pubmed">26816193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., 3rd, Bigio E.H., Caselli R., Baker M., Al-Lozi M.T., Morris J.C., Pestronk A., Rademakers R., Goate A.M., Cairns N.J. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 2008;63:535&#x2013;538. doi: 10.1002/ana.21344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21344</ArticleId><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Toledo E., Kelley R.E., Minagar A. Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis. Neurol. Res. 2006;28:280&#x2013;283. doi: 10.1179/016164106X98161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164106X98161</ArticleId><ArticleId IdType="pubmed">16687054</ArticleId></ArticleIdList></Reference><Reference><Citation>Govaerts K., Lechat B., Struys T., Kremer A., Borghgraef P., Van Leuven F., Himmelreich U., Dresselaers T. Longitudinal assessment of cerebral perfusion and vascular response to hypoventilation in a bigenic mouse model of Alzheimer's disease with amyloid and tau pathology. NMR Biomed. 2019;32 doi: 10.1002/nbm.4037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.4037</ArticleId><ArticleId IdType="pubmed">30489666</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Wang Q., Zhang K., An T., Shi P., Li Z., Duan W., Li C. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. 2012;1460:88&#x2013;95. doi: 10.1016/j.brainres.2012.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.04.003</ArticleId><ArticleId IdType="pubmed">22578468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammelrath L., Skokic S., Khmelinskii A., Hess A., van der Knaap N., Staring M., Lelieveldt B.P.F., Wiedermann D., Hoehn M. Morphological maturation of the mouse brain: an in vivo MRI and histology investigation. Neuroimage. 2016;125:144&#x2013;152. doi: 10.1016/j.neuroimage.2015.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2015.10.009</ArticleId><ArticleId IdType="pubmed">26458518</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton A.L., Hish G.A., Aslam M.N., Rothman E.D., Bergin I.L., Patterson K.A., Naik M., Paruchuri T., Varani J., Rush H.G. Progression of ulcerative dermatitis lesions in C57BL/6Crl mice and the development of a scoring system for dermatitis lesions. J. Am. Assoc. Lab. Anim. Sci. 2012;51:586&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3447447</ArticleId><ArticleId IdType="pubmed">23312087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., van den Berg L.H. Edaravone: a new treatment for ALS on the horizon? Lancet Neurol. 2017;16:490&#x2013;491. doi: 10.1016/S1474-4422(17)30163-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30163-1</ArticleId><ArticleId IdType="pubmed">28522180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrich K.S., Kochanek P.M., Melick J.A., Schiding J.K., Statler K.D., Williams D.S., Marion D.W., Ho C. Cerebral perfusion during anesthesia with fentanyl, isoflurane, or pentobarbital in normal rats studied by arterial spin-labeled MRI. Magn. Reson. Med. 2001;46:202&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">11443729</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdewyn S., Cirillo C., Van Den Bosch L., Robberecht W., Vanden Berghe P., Van Damme P. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Mol. Neurodegener. 2014;9:24. doi: 10.1186/1750-1326-9-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-24</ArticleId><ArticleId IdType="pmc">PMC4088917</ArticleId><ArticleId IdType="pubmed">24938805</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Mendez A., Almeida A., Fernandez E., Maestre C., Moncada S., Bolanos J.P. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell Biol. 2009;11:747&#x2013;752. doi: 10.1038/ncb1881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1881</ArticleId><ArticleId IdType="pubmed">19448625</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins B.G., Klivenyi P., Kustermann E., Andreassen O.A., Ferrante R.J., Rosen B.R., Beal M.F. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J. Neurochem. 2000;74:2108&#x2013;2119.</Citation><ArticleIdList><ArticleId IdType="pubmed">10800956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, S.G., Tsekos, N.V., 1997. Perfusion imaging by a flow-sensitive alternating inversion recovery (FAIR) technique: application to functional brain imaging (vol 37, pg 425, 1997). Magnet. Reson. Med. 37, 675&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pubmed">9055234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H., Dirren E., Poitry-Yamate C., Schneider B.L., Gruetter R., Aebischer P. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Cereb. Blood. Flow. 2018 doi: 10.1177/0271678X18756499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X18756499</ArticleId><ArticleId IdType="pmc">PMC6668519</ArticleId><ArticleId IdType="pubmed">29400109</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh, P.N., Whitwell, H., Garofalo, O., Buller, J., Swash, M., Martin, J.E., Gallo, J.M., Weller, R.O., Anderton, B.H., 1991. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114 (Pt 2), 775&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">1646064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner M., Bell T., Iqbal S., Mullins P.G., Christakou A. In vivo functional neurochemistry of human cortical cholinergic function during visuospatial attention. PLoS ONE. 2017;12 doi: 10.1371/journal.pone.0171338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0171338</ArticleId><ArticleId IdType="pmc">PMC5305251</ArticleId><ArticleId IdType="pubmed">28192451</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K., Masamoto K., Morimoto N., Kurata T., Mimoto T., Obata T., Kanno I., Abe K. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J. Cereb. Blood Flow Metab. 2012;32:456&#x2013;467. doi: 10.1038/jcbfm.2011.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.155</ArticleId><ArticleId IdType="pmc">PMC3293114</ArticleId><ArticleId IdType="pubmed">22068226</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan S., Francis S.J., Sled J.G., Santos A.C., Antel S., Levesque I., Brass S., Lapierre Y., Sappey-Marinier D., Pike G.B., Arnold D.L. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter. Neuroimage. 2006;29:637&#x2013;642. doi: 10.1016/j.neuroimage.2005.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2005.07.017</ArticleId><ArticleId IdType="pubmed">16126413</ArticleId></ArticleIdList></Reference><Reference><Citation>Naressi A., Couturier C., Castang I., de Beer R., Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput. Biol. Med. 2001;31:269&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">11334636</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. U S A. 1990;87:5144&#x2013;5147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54278</ArticleId><ArticleId IdType="pubmed">1973301</ArticleId></ArticleIdList></Reference><Reference><Citation>Ontaneda D., Sakaie K., Lin J., Wang X.F., Lowe M.J., Phillips M.D., Fox R.J. Measuring brain tissue integrity during 4 years using diffusion tensor imaging. AJNR Am. J. Neuroradiol. 2017;38:31&#x2013;38. doi: 10.3174/ajnr.A4946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4946</ArticleId><ArticleId IdType="pmc">PMC5233575</ArticleId><ArticleId IdType="pubmed">27659189</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosterlinck W.W., Dresselaers T., Geldhof V., Van Santvoort A., Robberecht W., Herijgers P., Himmelreich U. Response of mouse brain perfusion to hypo- and hyperventilation measured by arterial spin labeling. Magn. Reson. Med. 2011;66:802&#x2013;811. doi: 10.1002/mrm.23060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.23060</ArticleId><ArticleId IdType="pubmed">21748794</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin S. Preclinical research: make mouse studies work. Nature. 2014;507:423&#x2013;425. doi: 10.1038/507423a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/507423a</ArticleId><ArticleId IdType="pubmed">24678540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratiney H., Coenradie Y., Cavassila S., van Ormondt D., Graveron-Demilly D. Time-domain quantitation of 1H short echo-time signals: background accommodation. MAGMA. 2004;16:284&#x2013;296. doi: 10.1007/s10334-004-0037-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10334-004-0037-9</ArticleId><ArticleId IdType="pubmed">15168136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J., Paul P., Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571&#x2013;1575. doi: 10.1212/01.wnl.0000260965.20021.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rule R.R., Schuff N., Miller R.G., Weiner M.W. Gray matter perfusion correlates with disease severity in ALS. Neurology. 2010;74:821&#x2013;827. doi: 10.1212/WNL.0b013e3181d3e2dd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181d3e2dd</ArticleId><ArticleId IdType="pmc">PMC2839193</ArticleId><ArticleId IdType="pubmed">20147656</ArticleId></ArticleIdList></Reference><Reference><Citation>Struys T., Govaerts K., Oosterlinck W., Casteels C., Bronckaers A., Koole M., Van Laere K., Herijgers P., Lambrichts I., Himmelreich U., Dresselaers T. In vivo evidence for long-term vascular remodeling resulting from chronic cerebral hypoperfusion in mice. J. Cereb. Blood Flow Metab. 2017;37:726&#x2013;739. doi: 10.1177/0271678X16638349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X16638349</ArticleId><ArticleId IdType="pmc">PMC5381461</ArticleId><ArticleId IdType="pubmed">26994041</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenney J.R., Rozhkov L., Horn P., Miles L., Miles M.V. Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia. Epilepsia. 2014;55:1415&#x2013;1422. doi: 10.1111/epi.12731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12731</ArticleId><ArticleId IdType="pubmed">25053176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J., Jiang S., Ma X., Jiang Z., da Rocha E.L., Sheng M., Choi H., Lerou P.H., Li H., Wang X. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts M.E., Pocock R., Claudianos C. Brain energy and oxygen metabolism: emerging role in normal function and disease. Front. Mol. Neurosci. 2018;11:216. doi: 10.3389/fnmol.2018.00216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00216</ArticleId><ArticleId IdType="pmc">PMC6023993</ArticleId><ArticleId IdType="pubmed">29988368</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerasekera A., Sima D.M., Dresselaers T., Van Huffel S., Van Damme P., Himmelreich U. Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1(G93A) mouse model: a (1)H-magnetic resonance spectroscopic study. Neuroimage Clin. 2018;20:1092&#x2013;1105. doi: 10.1016/j.nicl.2018.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.09.011</ArticleId><ArticleId IdType="pmc">PMC6202692</ArticleId><ArticleId IdType="pubmed">30368196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U S A. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong K.P., Sha W., Zhang X., Huang S.C. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice. J. Nucl. Med. 2011;52:800&#x2013;807. doi: 10.2967/jnumed.110.085092.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.110.085092</ArticleId><ArticleId IdType="pmc">PMC3086987</ArticleId><ArticleId IdType="pubmed">21498533</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonas H., Sesay M., Calli C., Liu H.M., Lomena F., Nasel C., Meyer J.S., Yunten N., Anckarsater H., Wintermark M. The goal is quantitative cerebral blood flow. J. Neuroradiol. 2005;32:291&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer E.R., Parent M.J., Souza D.G., Leuzy A., Lecrux C., Kim H.I., Gauthier S., Pellerin L., Hamel E., Rosa-Neto P. [(18)F]FDG PET signal is driven by astroglial glutamate transport. Nat. Neurosci. 2017;20:393&#x2013;395. doi: 10.1038/nn.4492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4492</ArticleId><ArticleId IdType="pmc">PMC5378483</ArticleId><ArticleId IdType="pubmed">28135241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>